NVRO - Nevro Corp.

NYSE - NYSE Delayed Price. Currency in USD

61.03

-0.21 (-0.34%)

At close: 4:02PM EDT

61.03 0.00 (0.00%)
After hours: 5:02PM EDT

Stock chart is not supported by your current browser

Previous Close	61.24
Open	61.40
Bid	0.00 x 800
Ask	81.00 x 1000
Day's Range	60.89 - 61.64
52 Week Range	35.41 - 94.34
Volume	340,813
Avg. Volume	886,307

Market Cap	1.838B
Beta	-0.29
PE Ratio (TTM)	N/A
EPS (TTM)	-1.31
Earnings Date	Nov 5, 2018 - Nov 9, 2018
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	71.89

Trade prices are not sourced from all markets

All

News

Press Releases

Markit14 hours ago
See what the IHS Markit Score report has to say about Nevro Corp.
Short interest is moderate for NVRO with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, ETFs holding NVRO are favorable, with net inflows of $3.03 billion.
Thomson Reuters StreetEvents7 days ago
Edited Transcript of NVRO earnings conference call or presentation 2-Aug-18 8:30pm GMT
Q2 2018 Nevro Corp Earnings Call
Markit13 days ago
See what the IHS Markit Score report has to say about Nevro Corp.
Nevro Corp NYSE:NVRO
Zacks19 days ago
Nevro (NVRO) Reports Q2 Loss, Lags Revenue Estimates
Nevro (NVRO) delivered earnings and revenue surprises of -16.67% and -0.03%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Associated Press19 days ago
Nevro: 2Q Earnings Snapshot
The Redwood City, California-based company said it had a loss of 35 cents per share. The results did not meet Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment ...
PR Newswire19 days ago
Nevro Reports Second Quarter 2018 Financial Results
REDWOOD CITY, Calif. , Aug. 2, 2018 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today ...
ACCESSWIRE19 days ago
Nevro Corp. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / August 2, 2018 / Nevro Corp. (NYSE: NVRO ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 2, 2018 at 4:30 PM Eastern Time. To listen ...
PR Newswire23 days ago
Nevro Announces Patent Litigation Update
Parties File to Dismiss Remaining Claims - Boston Scientific Represents It Has No Plans to Launch High Frequency Products REDWOOD CITY, Calif. , July 30, 2018 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), ...
ACCESSWIRE27 days ago
Today's Research Reports on Stocks to Watch: Nevro and ViewRay
NEW YORK, NY / ACCESSWIRE / July 26, 2018 / Nevro and ViewRay were both big winners in Wednesday's trading session. Nevro announced a patent litigation update that had traders cheering while ViewRay appointed new people to its management team and announced encouraging preliminary results for the second quarter. Nevro Corp. shares closed up 35.71% on almost 5.4 million shares traded.
Benzinga27 days ago
Buying The Dip In Nevro Pays Off For Investors After Court Ruling
Prior to a big bounce Wednesday morning, Nevro Corp (NYSE: NVRO) stock was down nearly 50 percent in the past month. Much of the drop came Tuesday following what the market perceived as bad news tied to the company’s patent dispute with Boston Scientific Corporation (NYSE: BSX). A U.S. District Court ruled Tuesday that four of the seven patents involved in the dispute are invalid, and Boston Scientific was granted non-infringement on all remaining claims.
Motley Fool27 days ago
Why Nevro Corp. Stock Is Skyrocketing Today
Shares jump after the company reported a favorable litigation update related to its ongoing dispute with Boston Scientific.
Benzinga27 days ago
Benzinga Pro's 5 Stocks To Watch Today
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Ingersoll-Rand PLC (NYSE: IR ) stock was trading flat ...
ACCESSWIRE28 days ago
Today's Research Reports on Trending Tickers: Nevro and Stryker
NEW YORK, NY / ACCESSWIRE / July 25, 2018 / U.S. markets finished moderately higher on Tuesday, fueled by strong corporate earnings as Google quarterly results topped expectations. The Dow Jones Industrial ...
PR Newswire28 days ago
Nevro Announces Patent Litigation Update
Summary Judgment Ruling Affirms Method Claims Covering 1.5kHz to 100kHz Frequency Range REDWOOD CITY, Calif. , July 25, 2018 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical technology company ...
PR Newswirelast month
Nevro to Report Operating Results for the Second Quarter 2018
Nevro to Host Conference Call on Thursday, August 2, 2018 at 1:30 p.m. PT / 4:30 p.m. ET REDWOOD CITY, Calif. , July 19, 2018 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical technology company ...
Markitlast month
See what the IHS Markit Score report has to say about Nevro Corp.
Nevro Corp NYSE:NVRO
Zackslast month
Is the Options Market Predicting a Spike in Nevro (NVRO) Stock?
Investors need to pay close attention to Nevro (NVRO) stock based on the movements in the options market lately.
PR Newswirelast month
Nevro Announces Preliminary Unaudited Second Quarter 2018 Revenue and Updates Full Year 2018 Revenue Guidance
REDWOOD CITY, Calif., July 16, 2018 /PRNewswire/ -- Nevro Corp. (NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced preliminary unaudited revenue for the second quarter ended June 30, 2018. The company announced that preliminary unaudited second quarter 2018 worldwide revenue is expected to be approximately $96.1 million, compared to $78.0 million in the second quarter of 2017. The company expects worldwide revenue for the full year 2018 to be in the range of $385.0 to $390.0 million. This compares to previous expectations for 2018 worldwide revenue in the range of $400.0 to $410.0 million, as announced in May 2018.
ACCESSWIRElast month
Free Pre-Market Technical Recap on Nevro and Three Additional Medical Equipment Stocks
On Friday, July 13, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Six out of nine sectors ended Friday's trading session in bullish territories. Taking into consideration last Friday's market sentiment, WallStEquities.com assessed the following Medical Appliances & Equipment equities this morning: Nevro Corp. (NYSE: NVRO), NovoCure Ltd (NASDAQ: NVCR), NuVasive Inc. (NASDAQ: NUVA), and Stryker Corp. (NYSE: SYK).
Markitlast month
See what the IHS Markit Score report has to say about Nevro Corp.
Short interest is moderately high for NVRO with between 10 and 15% of shares outstanding currently on loan. Over the last one-month, outflows of investor capital in ETFs holding NVRO totaled $119 million.
PR Newswirelast month
Nevro to Announce Preliminary Second Quarter Worldwide Revenue, Discuss Full Year 2018 Revenue Guidance and Provide Business Updates
Company to Host Conference Call on Monday, July 16, 2018 at 5:30 a.m. PT / 8:30 a.m. ET REDWOOD CITY, Calif. , July 13, 2018 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that ...
Motley Foollast month
Here's Why Nevro Corp. Stock Is Falling Today
The company announced that a key executive has been terminated. Here's what investors need to know.
Benzinga2 months ago
3 Reasons Why Nevro Corp. Was Downgraded By Morgan Stanley
The bullish case for Nevro Corp (NYSE: NVRO ) — a medical device company that focuses on the treatment of chronic pain — no longer applies for three reasons, according to Morgan Stanley. The Analyst Morgan ...
GlobeNewswire2 months ago
Consolidated Research: 2018 Summary Expectations for Shake Shack, Gartner, Halyard Health, Liberty TripAdvisor, Tetra Tech, and Nevro — Fundamental Analysis, Key Performance Indications
NEW YORK, June 28, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Shake ...
Simply Wall St.2 months ago
Loss-Making Nevro Corp (NYSE:NVRO) Expected To Breakeven
Nevro Corp’s (NYSE:NVRO): Nevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally. The US$2.49b market-cap posted a lossRead More...